Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 10/2008

01.10.2008 | Original Article

Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies

verfasst von: Matthias Eder, Björn Wängler, Stefan Knackmuss, Fabrice LeGall, Melvyn Little, Uwe Haberkorn, Walter Mier, Michael Eisenhut

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The success of 68Ga-labeled peptides for positron emission tomography of neuroendocrine tumors is mainly depending on the complex chemistry of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins. Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins. They are suited to provide imaging contrast despite the short-lived 68Ga because of their rapid blood clearances and nanomolar affinities. The heterobifunctional agent N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [68Ga]Ga3+ much faster than DOTA at ambient temperatures.

Materials and methods

A versatile technology for HBED-CC conjugation of proteins and 68Ga-labeling has been developed. This included HBED-CC–tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.

Results

The synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used [Fe(HBED-CC)] for ester formation. The removal of Fe3+ from purified (HBED-CC)TFP ester was achieved with RP18 cartridge technology. The conjugation chemistry was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR). This protein was used for optimizing purposes only. The influence of complexation parameters like temperature, pH, reaction time, and HBED-CC/antibody ratio on the biological activity of this model antibody was investigated. Furthermore, the outcome of this labeling procedure on the biological activity of a recombinant diabody (50 kDa) was studied.

Conclusion

It is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains. Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient 68Ga labeling, pointing to the successful application of 68Ga for molecular imaging with small recombinant proteins.
Literatur
1.
Zurück zum Zitat Maecke HR, Hofmann M, Haberkorn U. 68Ga-labelled peptides in tumor imaging. J Nucl Med 2005;46(Suppl 1):172–8. Maecke HR, Hofmann M, Haberkorn U. 68Ga-labelled peptides in tumor imaging. J Nucl Med 2005;46(Suppl 1):172–8.
2.
Zurück zum Zitat Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM. Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Nature Biotechn 2004;22:701–6.CrossRef Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM. Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Nature Biotechn 2004;22:701–6.CrossRef
3.
Zurück zum Zitat Heppeler A, Froidevaux S, Maecke HR, Jermann E, Béhé M, Powell P, et al. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy. Chem Eur J 1999;5:1974–81.CrossRef Heppeler A, Froidevaux S, Maecke HR, Jermann E, Béhé M, Powell P, et al. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy. Chem Eur J 1999;5:1974–81.CrossRef
4.
Zurück zum Zitat Lewis MR, Raubitschek A, Shively JE. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabelled immunoconjugates. Bioconjug Chem 1994;5:565–76.PubMedCrossRef Lewis MR, Raubitschek A, Shively JE. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabelled immunoconjugates. Bioconjug Chem 1994;5:565–76.PubMedCrossRef
5.
Zurück zum Zitat Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, et al. In vitro characterization of radiolabelled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 2000;60:5237–43.PubMed Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, et al. In vitro characterization of radiolabelled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 2000;60:5237–43.PubMed
6.
Zurück zum Zitat Schuhmacher J, Matys R, Hauser H, Maier-Borst W, Matzku S. Labelling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labelling technique. Eur J Nucl Med 1986;12:397–404.PubMedCrossRef Schuhmacher J, Matys R, Hauser H, Maier-Borst W, Matzku S. Labelling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labelling technique. Eur J Nucl Med 1986;12:397–404.PubMedCrossRef
7.
Zurück zum Zitat Mathias CJ, Sun YZ, Welch MJ, Connett JM, Philpott GW, Martell AE. N,N′-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2 -ethylenediamine-N,N′-diacetic acid: a new bifunctional chelate for radiolabelling antibodies. Bioconjug Chem 1990;1:204–11.PubMedCrossRef Mathias CJ, Sun YZ, Welch MJ, Connett JM, Philpott GW, Martell AE. N,N′-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2 -ethylenediamine-N,N′-diacetic acid: a new bifunctional chelate for radiolabelling antibodies. Bioconjug Chem 1990;1:204–11.PubMedCrossRef
8.
Zurück zum Zitat Schuhmacher J, Klivenyl G, Hull WE, Matys R, Hauser H, Kalthoff H, et al. A bifunctional HBED-derivative for labelling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DTPA and 131I-labelled antibody internalizing and non-internalizing tumors. Nucl Med Biol 1992;19:809–24. Schuhmacher J, Klivenyl G, Hull WE, Matys R, Hauser H, Kalthoff H, et al. A bifunctional HBED-derivative for labelling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DTPA and 131I-labelled antibody internalizing and non-internalizing tumors. Nucl Med Biol 1992;19:809–24.
9.
Zurück zum Zitat Schuhmacher J, Maier-Borst W. A new Ge-68/Ga-68 radioisotope generator system for production of Ga-68 in dilute HCl. Int J Appl Radiat Isot 1981;32:31–6.CrossRef Schuhmacher J, Maier-Borst W. A new Ge-68/Ga-68 radioisotope generator system for production of Ga-68 in dilute HCl. Int J Appl Radiat Isot 1981;32:31–6.CrossRef
10.
Zurück zum Zitat Kipriyanov SM, Little M. Generation of recombinant antibodies. Mol Biotechnol 1999;12:173–201.PubMedCrossRef Kipriyanov SM, Little M. Generation of recombinant antibodies. Mol Biotechnol 1999;12:173–201.PubMedCrossRef
11.
Zurück zum Zitat Kipriyanov SM, Kupriyanova OA, Little M, Moldenhauer G. Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry. J Immunol Methods 1996;196:51–62.PubMedCrossRef Kipriyanov SM, Kupriyanova OA, Little M, Moldenhauer G. Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry. J Immunol Methods 1996;196:51–62.PubMedCrossRef
12.
Zurück zum Zitat Kipriyanov SM, Moldenhauer G, Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods 1997;200:69–77.PubMedCrossRef Kipriyanov SM, Moldenhauer G, Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods 1997;200:69–77.PubMedCrossRef
13.
Zurück zum Zitat Kipriyanov SM, Moldenhauer G, Martin AC, Kupriyanova OA, Little M. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Eng 1997;10:445–53.PubMedCrossRef Kipriyanov SM, Moldenhauer G, Martin AC, Kupriyanova OA, Little M. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Eng 1997;10:445–53.PubMedCrossRef
14.
Zurück zum Zitat Zöller M, Schuhmacher J, Reed J, Maier-Borst W, Matzku S. Establishment and characterization of monoclonal antibodies against an octahedral gallium chelate suitable for immunoscintigraphy with PET. J Nucl Med 1992;33:1366–72.PubMed Zöller M, Schuhmacher J, Reed J, Maier-Borst W, Matzku S. Establishment and characterization of monoclonal antibodies against an octahedral gallium chelate suitable for immunoscintigraphy with PET. J Nucl Med 1992;33:1366–72.PubMed
15.
Zurück zum Zitat Liu S, Edwards DS. Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconjug Chem 2001;12:7–34.PubMedCrossRef Liu S, Edwards DS. Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconjug Chem 2001;12:7–34.PubMedCrossRef
16.
Zurück zum Zitat Lewis MR, Kao JY, Anderson AL, Shively JE, Raubitschek A. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. Bioconjug Chem 2001;12:320–4.PubMedCrossRef Lewis MR, Kao JY, Anderson AL, Shively JE, Raubitschek A. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. Bioconjug Chem 2001;12:320–4.PubMedCrossRef
17.
Zurück zum Zitat Mier W, Hoffend J, Krämer S, Schuhmacher J, Hull WE, Eisenhut M, et al. Conjugation of DOTA using isolated phenolic active esters: the labelling and biodistribution of albumin as blood pool marker. Bioconjug Chem 2005;16:237–40.PubMedCrossRef Mier W, Hoffend J, Krämer S, Schuhmacher J, Hull WE, Eisenhut M, et al. Conjugation of DOTA using isolated phenolic active esters: the labelling and biodistribution of albumin as blood pool marker. Bioconjug Chem 2005;16:237–40.PubMedCrossRef
18.
Zurück zum Zitat Mier W, Haberkorn U, Eisenhut M. Synthesis and isolation of active esters of DOTA. J Labelled Comp Radiopharm 2001;44:814–6. Mier W, Haberkorn U, Eisenhut M. Synthesis and isolation of active esters of DOTA. J Labelled Comp Radiopharm 2001;44:814–6.
19.
Zurück zum Zitat Yokoyama A, Ohmomo Y, Horiuchi K, Saji H, Tanaka H, Yamamoto K, Ishii Y, Torizuka K. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication. J Nucl Med 1982;23:909–14.PubMed Yokoyama A, Ohmomo Y, Horiuchi K, Saji H, Tanaka H, Yamamoto K, Ishii Y, Torizuka K. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication. J Nucl Med 1982;23:909–14.PubMed
20.
Zurück zum Zitat Govindan SV, Michel RB, Griffiths GL, Goldenberg DM, Mattes MJ. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates. Nucl Med Biol 2005;32:513–9.PubMedCrossRef Govindan SV, Michel RB, Griffiths GL, Goldenberg DM, Mattes MJ. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates. Nucl Med Biol 2005;32:513–9.PubMedCrossRef
21.
Zurück zum Zitat Velikyan I, Maecke H, Langstrom B. Convenient Preparation of (68)Ga-Based PET-Radiopharmaceuticals at Room Temperature. Bioconjug Chem 2008;19:569–73.PubMedCrossRef Velikyan I, Maecke H, Langstrom B. Convenient Preparation of (68)Ga-Based PET-Radiopharmaceuticals at Room Temperature. Bioconjug Chem 2008;19:569–73.PubMedCrossRef
22.
Zurück zum Zitat Tait JF, Smith C, Levashova Z, Patel B, Blankenberg FG, Vanderheyden JL. Improved detection of cell death in vivo with annexin V radiolabelled by site-specific methods. J Nucl Med 2006;47:1546–53.PubMed Tait JF, Smith C, Levashova Z, Patel B, Blankenberg FG, Vanderheyden JL. Improved detection of cell death in vivo with annexin V radiolabelled by site-specific methods. J Nucl Med 2006;47:1546–53.PubMed
23.
Zurück zum Zitat Eisenhut M, Haberkorn U. Invited perspective: the molecular position of radiolabels and its impact on functional integrity of proteins. J Nucl Med 2006;47:1400–2.PubMed Eisenhut M, Haberkorn U. Invited perspective: the molecular position of radiolabels and its impact on functional integrity of proteins. J Nucl Med 2006;47:1400–2.PubMed
Metadaten
Titel
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies
verfasst von
Matthias Eder
Björn Wängler
Stefan Knackmuss
Fabrice LeGall
Melvyn Little
Uwe Haberkorn
Walter Mier
Michael Eisenhut
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2008
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0816-z

Weitere Artikel der Ausgabe 10/2008

European Journal of Nuclear Medicine and Molecular Imaging 10/2008 Zur Ausgabe